Borsi L - Search Results

1

Procedure for the purification of the fibronectin proteolytic fragments containing the ED-B oncofetal domain.

Borsi L, Balza E, Leprini A, Ponassi M, Zardi L. Borsi L, et al. Anal Biochem. 1991 Feb 1;192(2):372-9. doi: 10.1016/0003-2697(91)90551-4. Anal Biochem. 1991. PMID: 2035837

2

Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues.

Borsi L, Balza E, Allemanni G, Zardi L. Borsi L, et al. Exp Cell Res. 1992 Mar;199(1):98-105. doi: 10.1016/0014-4827(92)90466-l. Exp Cell Res. 1992. PMID: 1310473

3

Expression of tenascin and of the ED-B containing oncofetal fibronectin isoform in human cancer.

Nicolò G, Salvi S, Oliveri G, Borsi L, Castellani P, Zardi L. Nicolò G, et al. Among authors: borsi l. Cell Differ Dev. 1990 Dec 2;32(3):401-8. doi: 10.1016/0922-3371(90)90056-3. Cell Differ Dev. 1990. PMID: 1711919 Review.

4

Elution of fibronectin proteolytic fragments from a hydroxyapatite chromatography column. A simple procedure for the purification of fibronectin domains.

Zardi L, Carnemolla B, Balza E, Borsi L, Castellani P, Rocco M, Siri A. Zardi L, et al. Among authors: borsi l. Eur J Biochem. 1985 Feb 1;146(3):571-9. doi: 10.1111/j.1432-1033.1985.tb08690.x. Eur J Biochem. 1985. PMID: 2982601 Free article.

5

Large-scale procedure for the purification of fibronectin domains.

Borsi L, Castellani P, Balza E, Siri A, Pellecchia C, De Scalzi F, Zardi L. Borsi L, et al. Anal Biochem. 1986 Jun;155(2):335-45. doi: 10.1016/0003-2697(86)90443-4. Anal Biochem. 1986. PMID: 3728983

6

Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin.

Borsi L, Balza E, Bestagno M, Castellani P, Carnemolla B, Biro A, Leprini A, Sepulveda J, Burrone O, Neri D, Zardi L. Borsi L, et al. Int J Cancer. 2002 Nov 1;102(1):75-85. doi: 10.1002/ijc.10662. Int J Cancer. 2002. PMID: 12353237

7

A novel human fibronectin cryptic sequence unmasked by the insertion of the angiogenesis-associated extra type III domain B.

Balza E, Sassi F, Ventura E, Parodi A, Fossati S, Blalock W, Carnemolla B, Castellani P, Zardi L, Borsi L. Balza E, et al. Among authors: borsi l. Int J Cancer. 2009 Aug 15;125(4):751-8. doi: 10.1002/ijc.24473. Int J Cancer. 2009. PMID: 19479996 Free article.

8

Comparison of human tenascin expression in normal, simian-virus-40-transformed and tumor-derived cell lines.

Carnemolla B, Borsi L, Bannikov G, Troyanovsky S, Zardi L. Carnemolla B, et al. Among authors: borsi l. Eur J Biochem. 1992 Apr 15;205(2):561-7. doi: 10.1111/j.1432-1033.1992.tb16813.x. Eur J Biochem. 1992. PMID: 1374030 Free article.

9

Transforming growth factor-beta regulates the splicing pattern of fibronectin messenger RNA precursor.

Borsi L, Castellani P, Risso AM, Leprini A, Zardi L. Borsi L, et al. FEBS Lett. 1990 Feb 12;261(1):175-8. doi: 10.1016/0014-5793(90)80664-5. FEBS Lett. 1990. PMID: 2307231 Free article.

10

Transforming growth factor beta regulates the levels of different fibronectin isoforms in normal human cultured fibroblasts.

Balza E, Borsi L, Allemanni G, Zardi L. Balza E, et al. Among authors: borsi l. FEBS Lett. 1988 Feb 8;228(1):42-4. doi: 10.1016/0014-5793(88)80580-5. FEBS Lett. 1988. PMID: 3422628 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters